13:30 - 13:45 Opening

• U Yılmaz (Türkiye)

13:45 - 14:30 Session 1: New classification and epidemiology of T cell diseases

Chair: S Koçak (Türkiye)

• Updated classification and molecular evaluation of nodal T-cell lymphomas
  V Tabanelli (Italy)
  

14:30 - 16:00 Session 2: How I treat PTCL NOS patients

Chair: E Birtaş Ateşoğlu (Türkiye)

• Treatment of PTCL-NOS patients
  E Birtaş Ateşoğlu (Türkiye)
  
• Clinical Case
  E Kırcalı (Türkiye)
• Self-assessment Case
  E Birtaş Ateşoğlu (Türkiye)
  

16:00 - 16:30 Coffee break

16:30 - 18:00 Session 3: First line treatment of ALCL according to prognostic factors

Chair: Ö Mehtap (Türkiye)

• First line treatment of systemic ALCL – new developments and controversies
  T Illidge (United Kingdom)
• Clinical Case
  U Yılmaz (Türkiye)
• Self-assessment Case
  T Illidge (United Kingdom)
  

08:30 - 10:00 Session 4: Treatment approaches in R/R PTCL

Chair: E Birtaş Ateşoğlu (Türkiye)

• Therapeutic options in relapsed/refractory Peripheral T-cell lymphomas
  F Lemonnier (France)
  
• Clinical Case
  M Uluköylü Mengüç (Türkiye)
  
• Self-assessment Case
  F Lemonnier (France)
  

10:00 - 11:30 Session 5: Treatment approaches in NK/T cell lymphoma nasal type

Chair: Ö Mehtap (Türkiye)

• NK/T cell lymphoma nasal type
  D El-Sharkawi (United Kingdom)
  
• Clinical Case
  S Küçükyurt (Türkiye)
  
• Self-assessment Case
  D El-Sharkawi (United Kingdom)
  

11:30 - 12:00 Coffee break

12:00 - 13:30 Session 6: Treatment approaches in MF and Sezary Syndrome

Chair: S Koçak (Türkiye)

• Therapeutic management of relapsed/refractory mycosis fungoides and Sezary Syndrome
  M Siakantaris (Greece)
  
• Clinical Case
  F Keklik Karadağ (Türkiye)
  
• Self-assessment Case
  M Siakantaris (Greece)
  

13:30 - 13:45 Closing

• MC Ar (Türkiye)